comparemela.com

Latest Breaking News On - Sealand securities - Page 6 : comparemela.com

China s yuan firms as monetary easing expected, little impact from Evergrande

China's yuan firmed on Monday, as Chinese exporters sold dollars with the approach of the year end, and investors expected the economy to strengthen took heart from expectations for monetary loosening that should boost the economy.

China property shares stumble on tax worry, signs of weakness

Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.

China Property Shares Stumble on Tax Worry, Signs of Weakness

China Digest: TYK Medicines bags $62m; TAOS Data raises $47m led by Matrix Partners China

China Digest: TYK Medicines bags $62m; TAOS Data raises $47m led by Matrix Partners China Source: Jan Antonin Kolar/Unsplash May 24, 2021 TYK Medicines has garnered nearly 400 million yuan ($62 million) in a Series B+ round led by Sealand Innovation, while TAOS Data has secured $47 million in a Series B round led by Matrix Partners China. TYK Medicines bags nearly $62m Series B+ Chinese biopharmaceutical firm TYK Medicines has garnered nearly 400 million yuan ($62 million) in a Series B+ round of financing led by Sealand Innovation, a 17.6 billion yuan ($2.7 billion) fund owned by Sealand Securities, according to a company statement on Monday. The round also saw participation from Haibang Investment and Zheshang Venture Capital, a Hangzhou-based investment firm that has invested in fresh produce e-commerce platform MissFresh; ride-hailing player Caocao; and cloud video provider Arcvideo Tech, among others.

China Medical System (0867 HK) Acquires a Dermatology Specialty Company: A Tough Player the Race

China Medical System (0867.HK) Acquires a Dermatology Specialty Company: A Tough Player the Race By GeLongHui HONG KONG, Feb 5, 2021 - (ACN Newswire) - On February 1, China Medical System (0867.HK) announced that its subsidiary had acquired Luqa Ventures Co., Limited ( Luqa ), a dermatology specialty company. This acquisition expanded its product portfolio to include Luqa s dermatology products and marked the first foray into the medical aesthetic industry for China Medical System. Why medical aesthetics? What is the significance of this acquisition? 1. Consolidating the Skin Management Business and Entering the Medical Aesthetic Market: Acquiring Luqa to Explore a New Growth Engine According to its official website, established in 2010, Luqa is an innovative enterprise with skin treatment and medical aesthetic solutions as its core business.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.